Considering the positive correlation between CD133+ CSCs and CK19+ TB in patients with PDAC (Supplementary Figure S3C, S3F, & S3I), we concluded that CD133+ CSCs have a high metastatic potential. The gene discussed is KRT19; the disease is tuberculosis.